BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36453008)

  • 1. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.
    Singh A; Midha V; Narang V; Kedia S; Mahajan R; Dhoble P; Kahlon BK; Dhaliwal AS; Tripathi A; Kalra S; Jain NP; Bansal N; Banerjee R; Desai D; Dutta U; Ahuja V; Sood A
    Intest Res; 2023 Oct; 21(4):452-459. PubMed ID: 36453008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
    Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J
    Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
    Catassi G; D'Arcangelo G; Norsa L; Bramuzzo M; Hojsak I; Kolho KL; Romano C; Gasparetto M; Di Giorgio A; Hussey S; Yerushalmy-Feler A; Turner D; Matar M; Weiss B; Karoliny A; Alvisi P; Tzivinikos C; Aloi M
    Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37768032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
    Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
    Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis and its relationship to the colon in a black cohort of inflammatory bowel disease patients.
    Koczka CP; Geraldino-Pardilla LB; Lawlor G
    J Clin Gastroenterol; 2014 Feb; 48(2):e19-21. PubMed ID: 24402121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.
    Rennebaum F; Demmig C; Schmidt HH; Vollenberg R; Tepasse PR; Trebicka J; Gu W; Ullerich H; Kabar I; Cordes F
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
    Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
    World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children.
    Yoon J; Oh SH; Kim HJ; Park SH; Ye BD; Yang SK; Kim KM
    Pediatr Gastroenterol Hepatol Nutr; 2015 Dec; 18(4):268-75. PubMed ID: 26770902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.